ANVISA Audit, Gap Analysis and Regulatory Compliance

Before the Inspection, Certification or Investment: Know Exactly Which Risks Need to Be Addressed

Facing an imminent health inspection or planning an industrial expansion demands complete technical clarity. Kivalita performs in-depth audits and Gap Analyses to map regulatory, documentary, operational and strategic gaps. We help your company prioritize corrective actions and mitigate critical risks before official inspections, product registrations, GMP (Good Manufacturing Practice) certifications or high-impact decisions.

When to Hire Us

If your company or regulated industry is at one of the strategic moments below, our regulatory assessment is the ideal starting point to protect your operation:

  • Before an ANVISA Inspection: Get ahead of the inspectors, validate your GxP routines and eliminate bottlenecks that could lead to infraction notices or shutdowns.
  • Before a Product Registration: Make sure all documentation, dossiers and technical workflows are fully aligned with current requirements before submission.
  • Before a Certification or Recertification: Assess your technical compliance with good practices (GMP, GDP and related standards) to secure the issuance or renewal of your certificate without delays.
  • Before Hiring a Critical Supplier: Mitigate supply chain risks through robust, outsourced qualification audits.
  • After Deviations, Complaints or Audits with Open CAPAs: Organize and investigate recurring deviations that compromise the safety of your processes and products.
  • Before Investing in Strategic Assets: Thoroughly assess regulatory feasibility before committing capital to new plants, laboratories, complex systems, suppliers or registrations.

Regulatory Anamnesis

Gap Analysis: The Regulatory Anamnesis of Your Business

Just as a detailed medical diagnosis maps a patient’s health before any intervention, Gap Analysis acts as your company’s regulatory anamnesis. It precisely identifies your current situation, points out existing gaps against ANVISA regulations, collects real evidence, classifies the criticality of risks and outlines the safest, most efficient strategic paths before you execute or invest in the final project.

Delivery Process

The Kivalita Method: How We Turn Gaps into Effective Action Plans

Our delivery process is structured in clear stages to ensure technical rigor and full transparency throughout the audit:

  1. Aligned Technical Interviews: We work closely with key managers and operators to understand the daily reality of your workflows.
  2. In-Depth Document Review: We critically analyze manuals, SOPs, validation reports, deviation records and all mandatory documentation.
  3. On-Site Process Assessment: We verify the practical application of GxP routines in production, storage and laboratory areas, identifying real bottlenecks.
  4. Criticality Classification: We categorize each vulnerability found using a Regulatory Risk Matrix, separating what is immediate from what is strategic.
  5. Prioritized Compliance Plan: We deliver a complete, time-bound action plan focused on efficiently resolving technical and regulatory pending items.

Continuous K for CAPAs

Efficient Post-Audit Support: Turn Action Plans into Continuous Compliance with Continuous K

An audit or Gap Analysis only fulfills its purpose if the bottlenecks it identifies are actually resolved. To make sure your company does not miss regulatory deadlines, we developed Continuous K: an intelligent follow-up system focused on the progress of your corrective and preventive actions. More than delivering a report of findings, our consultancy stays by your side after the audit to untangle the most complex operational issues:

  • Open CAPA Management: Rigorous monitoring of action plans to reduce the risk of new findings.
  • Handling Recurring Deviations: Root cause investigation to permanently eliminate failures that keep reappearing in your GxP routine.
  • Improvement Opportunities: Turning technical vulnerabilities into operational efficiency and optimized processes.
  • Closure Evidence: Structuring and reviewing all supporting documentation to present to ANVISA with full confidence.

Is your company truly prepared for the next ANVISA inspection?

Don’t wait for an inspection to uncover flaws that can halt your operation, generate fines or delay registrations. Talk to Kivalita’s specialists and schedule your preventive audit.

Who Is This For

I Need Supplier Qualification and/or GMP Audits at My Company. What Is the Best Option?

PERIODIC AUDIT CONTRACT

For companies that want to carry out domestic or international audits at a predictable monthly cost, under a six-month or annual contract.

  • Define how many audits you need per month, based on an audit priority schedule;
  • Categorize suppliers to be audited according to their criticality to the business or to legislation and good practices;
  • Cap the number of audits per month to fit your budget;
  • Audits that consider applicable legislation (GMP), business strategy and/or ISO standards.

Contract terms: minimum of 6 to 24 months.

ONE-TIME AUDITS

A solution for those who need a one-off internal assessment (for ISO or GMP) or a single audit of a specific supplier.

  • Choose the type of audit you want and focus it as needed (ISO, ONA, RDCs, GMP, etc.);
  • Receive a complete report to support decisions about the gaps detected;
  • List your business strategy needs and verify whether the departments (or the supplier) are meeting them.

Contract terms: single-delivery service.

FAQ: ANVISA Audit, Gap Analysis and Regulatory Compliance

Does Kivalita’s Gap Analysis replace a routine internal audit?

It goes further. While an internal audit verifies compliance with existing procedures, Gap Analysis evaluates the company’s strategic alignment with new regulations or major changes (such as an upcoming inspection or expansion), mapping risks predictively.

We use well-established regulatory risk analysis methodologies, classifying findings as Critical, Major and Minor, so your leadership knows exactly where to invest resources first.

Yes. Through our Continuous K methodology, a mentoring and consulting program delivered by our multidisciplinary team, we follow and support your Quality team in closing CAPAs and structuring the evidence for ANVISA.

Request a Quote Now

We have extensive experience delivering solutions for pharmaceutical, food, cosmetics, sanitizing products and veterinary industries.

By submitting my information, I agree to the Privacy Policy.
Hello! Fill in the fields below to start a conversation on WhatsApp
By providing my data, I agree to the Privacy policies